Large scale gene set ranking for survival-related gene sets

IF 6.2 2区 医学 Q1 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE
Martin Špendl , Jaka Kokošar , Ela Praznik , Luka Ausec , Miha Štajdohar , Blaž Zupan
{"title":"Large scale gene set ranking for survival-related gene sets","authors":"Martin Špendl ,&nbsp;Jaka Kokošar ,&nbsp;Ela Praznik ,&nbsp;Luka Ausec ,&nbsp;Miha Štajdohar ,&nbsp;Blaž Zupan","doi":"10.1016/j.artmed.2025.103149","DOIUrl":null,"url":null,"abstract":"<div><div>Disease progression is closely linked to shifts in the expression levels of specific genes within molecular pathways. While gene set enrichment analysis is a widely employed method for identifying key disease markers, it has been underutilized in survival analysis. Here, we introduce a novel computational approach that adapts gene set enrichment analysis for survival analysis. The proposed approach considers a gene set, computes a single-sample gene set enrichment score, and, based on this score, splits the samples into cohorts. It then scores the gene sets by evaluating the differences in survival rates between the resulting cohorts. We aim to find gene sets that can lead to cohorts with significantly different survival probabilities. Utilizing gene expression data from The Cancer Genome Atlas and gene sets from the Molecular Signature Database, our results demonstrate that existing empirical research consistently supports the top gene sets our approach associates with survival prognosis. The proposed method broadens gene set enrichment analysis applications to include information on survival, bridging the gap between alterations in molecular pathways and their implications on survival.</div></div>","PeriodicalId":55458,"journal":{"name":"Artificial Intelligence in Medicine","volume":"167 ","pages":"Article 103149"},"PeriodicalIF":6.2000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial Intelligence in Medicine","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0933365725000843","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0

Abstract

Disease progression is closely linked to shifts in the expression levels of specific genes within molecular pathways. While gene set enrichment analysis is a widely employed method for identifying key disease markers, it has been underutilized in survival analysis. Here, we introduce a novel computational approach that adapts gene set enrichment analysis for survival analysis. The proposed approach considers a gene set, computes a single-sample gene set enrichment score, and, based on this score, splits the samples into cohorts. It then scores the gene sets by evaluating the differences in survival rates between the resulting cohorts. We aim to find gene sets that can lead to cohorts with significantly different survival probabilities. Utilizing gene expression data from The Cancer Genome Atlas and gene sets from the Molecular Signature Database, our results demonstrate that existing empirical research consistently supports the top gene sets our approach associates with survival prognosis. The proposed method broadens gene set enrichment analysis applications to include information on survival, bridging the gap between alterations in molecular pathways and their implications on survival.
生存相关基因集的大规模基因集排序
疾病进展与分子通路中特定基因表达水平的变化密切相关。虽然基因集富集分析是一种广泛使用的识别关键疾病标志物的方法,但它在生存分析中的应用不足。在这里,我们介绍了一种新的计算方法,使基因集富集分析适应于生存分析。提出的方法考虑一个基因集,计算一个单样本基因集富集分数,并基于这个分数,将样本分成队列。然后通过评估结果组之间存活率的差异对基因组进行评分。我们的目标是找到能够导致具有显著不同生存概率的队列的基因集。利用来自癌症基因组图谱的基因表达数据和来自分子特征数据库的基因集,我们的研究结果表明,现有的实证研究一致支持我们的方法与生存预后相关的顶级基因集。所提出的方法拓宽了基因集富集分析的应用,包括生存信息,弥合了分子途径的改变及其对生存的影响之间的差距。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Artificial Intelligence in Medicine
Artificial Intelligence in Medicine 工程技术-工程:生物医学
CiteScore
15.00
自引率
2.70%
发文量
143
审稿时长
6.3 months
期刊介绍: Artificial Intelligence in Medicine publishes original articles from a wide variety of interdisciplinary perspectives concerning the theory and practice of artificial intelligence (AI) in medicine, medically-oriented human biology, and health care. Artificial intelligence in medicine may be characterized as the scientific discipline pertaining to research studies, projects, and applications that aim at supporting decision-based medical tasks through knowledge- and/or data-intensive computer-based solutions that ultimately support and improve the performance of a human care provider.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信